PACS Q3 2026 slides: 34% EBITDA growth, Florida expansion detailed

PACS Group (NYSE:PACS) reported Q3 2026 revenue of $1.5B (+11.5% YoY) and adjusted EBITDA of $654.9M (+33.6% YoY). Despite missing GAAP EPS estimates, shares rose 10.63% after-hours on strong margin expansion and raised full-year guidance. The company expanded to 21 states with strategic acquisitions, including 32 Florida facilities.

Original reporting
Published Nov 4, 2026, 5:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 5:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PACS
Bullish
high confidence
Mentioned
$PACS
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$PACSBullishMed
01

Why it matters

The key tradable update is the raised FY 2026 revenue and adjusted EBITDA guidance, supported by improved adjusted EBITDA margin and occupancy, which can offset the GAAP EPS miss.

02

Market read

Guidance raise plus margin and occupancy improvements are likely to drive near-term positioning in PACS and influence sentiment toward SNF operators.

03

What to watch

The guidance assumes contributions from specific acquired facilities and retroactive incentive payments; if occupancy or quality metrics lag in new sites, the EBITDA ramp may be less durable.

Relevance 8/10Novelty 7/10Timing: after-hours reaction to Q3 2026 earnings and same-day guidance raise

Background

PACS is a skilled nursing facility operator expanding via acquisitions, with investors tracking both occupancy/quality metrics and integration costs.

Company-level read

Ticker impact

$PACSBullishHigh confidence
Context

PACS reported Q3 2026 results and raised full-year guidance, including adjusted EBITDA growth and Florida/Texas expansion details.

Expected impact

Likely upward pressure as investors focus on raised guidance and operating leverage rather than GAAP integration and legal costs.

Evidence & confidence

The article states management raised FY 2026 revenue and adjusted EBITDA ranges and highlights improved adjusted EBITDA margin, which are direct drivers of valuation expectations.

Market effects

Reinforces the skilled nursing consolidation and operating-leverage narrative, potentially supporting sentiment toward other SNF operators with similar scale and quality metrics.

Florida expansion via acquired facilities increases exposure to that state’s regulatory and reimbursement environment.

Limited direct global linkage; primarily a US healthcare services read-through.

Counterpoint

The GAAP EPS miss and cited integration, stock-based comp, and legal costs tied to expansion and investigations could foreshadow margin volatility or higher-than-expected expenses.

Key entities

  • PACS Group

    Skilled nursing facility operator reporting Q3 2026 results and raising full-year 2026 guidance, with expansion into Florida and Texas.

  • Omega Healthcare Investors

    Leased Florida facilities referenced in the article as part of PACS’s statewide entry.

Related articles

$PACSMedAI 8/10

What PACS Group (PACS) Said on Its Q3 Earnings Call

PACS Group reported 196 mature, 90 ramping, and 35 new skilled nursing facilities with occupancy ranging from 76.2% to 93.1%. The company acquired 32 Florida and 10 Texas skilled nursing operations post-quarter. PACS raised its 2026 revenue outlook to $5.95B-$6.05B and adjusted EBITDA to $685M-$695M, citing strength in existing operations and new acquisitions. Operating cash flow was $583.1M for the first nine months of 2026, with $707.4M in available liquidity.

$PACSHighAI 8/10

PACS Group Inc (PACS) (Q3 2026) Earnings Call Highlights: Revenue Tops

PACS Group Inc (NYSE:PACS) reported Q3 2026 revenue growth of 6.4%, with adjusted EBITDA up 33.6% to $175.7M. The company raised full-year guidance, citing strong occupancy and skilled mix improvements. PACS also highlighted a robust acquisition pipeline and integration plans for 31 Eduro facilities. Challenges include lower metrics at newly acquired facilities and ongoing government investigations.

$PACSHigh

Why is PACS stock surging today?

PACS Group Inc (PACS) stock rose 6.0% in after-hours trading after beating Q3 2026 earnings and revenue estimates. The company also raised its full-year 2026 Adjusted EBITDA and revenue guidance. Analysts maintain a 'Moderate Buy' rating with an average price target of $58.80. The surge was driven by company-specific news.

$PACSHigh

PACS Group, Inc. Reports Third Quarter 2026 Results

PACS Group, Inc. (PACS) filed an SEC Form 8-K — Results of Operations and Financial Condition. PACS Group, Inc. Reports Third Quarter 2026 Results Conference Call and Webcast Scheduled for Tomorrow, November 4, 2026, at 11:30 am ET. SALT LAKE CITY, Utah, November 3, 2026 – PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one